These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10581593)

  • 1. Combined hyperinsulinaemic glucose clamp and oral acipimox for optimizing metabolic conditions during 18F-fluorodeoxyglucose gated PET cardiac imaging: comparative results.
    Schröder O; Hör G; Hertel A; Baum RP
    Nucl Med Commun; 1998 Sep; 19(9):867-74. PubMed ID: 10581593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols.
    Bax JJ; Veening MA; Visser FC; van Lingen A; Heine RJ; Cornel JH; Visser CA
    Eur J Nucl Med; 1997 Jan; 24(1):35-41. PubMed ID: 9044874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac 18F-FDG-SPET studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping.
    Bax JJ; Visser FC; Raymakers PG; Van Lingen A; Cornel JH; Huitink JM; Elhendy A; Heine RJ; Visser CA
    Nucl Med Commun; 1997 Mar; 18(3):200-6. PubMed ID: 9106773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of myocardial [fluorine-18]fluorodeoxyglucose uptake by a nicotinic acid derivative.
    Knuuti MJ; Yki-Järvinen H; Voipio-Pulkki LM; Mäki M; Ruotsalainen U; Härkönen R; Teräs M; Haaparanta M; Bergman J; Hartiala J; Wegelius U; Nuutila P
    J Nucl Med; 1994 Jun; 35(6):989-98. PubMed ID: 8195886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility, safety and image quality of cardiac FDG studies during hyperinsulinaemic-euglycaemic clamping.
    Bax JJ; Visser FC; Poldermans D; van Lingen A; Elhendy A; Boersma E; Visser CA
    Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):452-7. PubMed ID: 11914881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and feasibility of cardiac FDG SPECT following oral administration of Acipimox, a nicotinic acid derivative: Comparison of image quality with hyperinsulinemic euglycemic clamping in nondiabetic patients.
    Bax JJ; Visser FC; Poldermans D; Van Lingen A; Elhendy A; Boersma E; Sloof GW; Visser CA
    J Nucl Cardiol; 2002; 9(6):587-93. PubMed ID: 12466782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability.
    Schinkel AF; Bax JJ; Valkema R; Elhendy A; van Domburg RT; Vourvouri EC; Bountioukos MA; Krenning EP; Roelandt JR; Poldermans D
    J Nucl Med; 2003 Jun; 44(6):877-83. PubMed ID: 12791813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ECG-triggered 18F-fluorodeoxyglucose positron emission tomography imaging of the rat heart is dramatically enhanced by acipimox.
    Poussier S; Maskali F; Tran N; Person C; Maureira P; Boutley H; Karcher G; Lacolley P; Régnault V; Fay R; Marie PY
    Eur J Nucl Med Mol Imaging; 2010 Aug; 37(9):1745-50. PubMed ID: 20393712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Appropriate uptake period for myocardial PET imaging with 18F-FDG after oral glucose loading].
    Brink I; Nitzsche EU; Mix M; Schindler T; Hentschel M; Högerle S; Moser E
    Nuklearmedizin; 2003 Feb; 42(1):39-44. PubMed ID: 12601453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration.
    Kam BL; Valkema R; Poldermans D; Bax JJ; Reijs AE; Rambaldi R; Boersma E; Rietveld T; Roelandt JR; Krenning EP
    J Nucl Med; 2003 Feb; 44(2):140-5. PubMed ID: 12571201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acipimox does not augment thallium-201 redistribution in the fasting state.
    Gunning MG; Clunie G; Yepes-Mora S; Eastick S; Underwood SR; Bomanji J; Ell PJ
    J Nucl Cardiol; 1999; 6(6):620-5. PubMed ID: 10608589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Euglycemic hyperinsulinemic clamp and oral glucose load in stimulating myocardial glucose utilization during positron emission tomography.
    Knuuti MJ; Nuutila P; Ruotsalainen U; Saraste M; Härkönen R; Ahonen A; Teräs M; Haaparanta M; Wegelius U; Haapanen A
    J Nucl Med; 1992 Jul; 33(7):1255-62. PubMed ID: 1613561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial glucose uptake evaluated by positron emission tomography and fluorodeoxyglucose during hyperglycemic clamp in IDDM patients. Role of free fatty acid and insulin levels.
    Monti LD; Lucignani G; Landoni C; Moresco RM; Piatti P; Stefani I; Pozza G; Fazio F
    Diabetes; 1995 May; 44(5):537-42. PubMed ID: 7729612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncoupling of fatty acid and glucose metabolism in malignant lymphoma: a PET study.
    Nuutinen J; Minn H; Bergman J; Haaparanta M; Ruotasalainen U; Laine H; Knuuti J
    Br J Cancer; 1999 May; 80(3-4):513-8. PubMed ID: 10408861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of arterialised venous instead of arterial blood for measurement of myocardial glucose metabolism during euglycaemic-hyperinsulinaemic clamping.
    van der Weerdt AP; Klein LJ; Visser CA; Visser FC; Lammertsma AA
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):663-9. PubMed ID: 11976805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of high and low plasma insulin levels on the uptake of fluorine-18 fluorodeoxyglucose in myocardium and femoral muscle, assessed by planar imaging.
    Huitink JM; Visser FC; van Leeuwen GR; van Lingen A; Bax JJ; Heine RJ; Teule GJ; Visser CA
    Eur J Nucl Med; 1995 Oct; 22(10):1141-8. PubMed ID: 8542898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus.
    Saloranta C; Franssila-Kallunki A; Ekstrand A; Taskinen MR; Groop L
    Diabetologia; 1991 Jun; 34(6):409-15. PubMed ID: 1884899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different acute and chronic effects of acipimox treatment on glucose and lipid metabolism in patients with type 2 diabetes.
    Saloranta C; Groop L; Ekstrand A; Franssila-Kallunki A; Eriksson J; Taskinen MR
    Diabet Med; 1993 Dec; 10(10):950-7. PubMed ID: 8306591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simple quantification of skeletal muscle glucose utilization by static 18F-FDG PET.
    Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R
    J Nucl Med; 2003 Oct; 44(10):1592-8. PubMed ID: 14530472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.